Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pentokey Organy (India)'s EBIT per Share for the
three
months ended in Mar. 2026 was ₹-0.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.54.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pentokey Organy (India)'s EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pentokey Organy (India) was 120.80% per year. The lowest was -18.10% per year. And the median was 20.70% per year.
BOM:524210's 3-Year EBIT Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -0.9 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Pentokey Organy (India) (BOM:524210) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pentokey Organy (India) EBIT per Share Related Terms
Pentokey Organy (India) EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pentokey Organy (India) (BOM:524210) has a EBIT per Share of ₹0.54 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pentokey Organy (India) and its competitors. According to the industry distribution chart, Pentokey Organy (India) ranks #999999 out of 1337 companies in the Chemicals industry.
Is Pentokey Organy (India)'s EBIT per Share too high?
Pentokey Organy (India)'s current EBIT per Share is ₹0.54. Based on the distribution chart, Pentokey Organy (India) ranks #999999 out of 1337 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Pentokey Organy (India) has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pentokey Organy (India)'s EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Pentokey Organy (India) ranks #999999 out of 1337 companies for EBIT per Share. This places Pentokey Organy (India) in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pentokey Organy (India) and its competitors. Pentokey Organy (India)'s current EBIT per Share is ₹0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentokey Organy (India) stock overvalued right now?
Based on GuruFocus' analysis, Pentokey Organy (India) (BOM:524210) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹25.68, compared to a current price of ₹32.83 — trading 27.8% above its estimated fair value. The current EBIT per Share is ₹0.54. Pentokey Organy (India)'s overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Pentokey Organy (India) (BOM:524210), the current EBIT per Share is ₹0.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pentokey Organy (India) (BOM:524210) Overvalued in 2026?
Based on GuruFocus' analysis, Pentokey Organy (India) stock appears to be overvalued.
The current stock price of ₹32.83 is trading 27.8% above its estimated GF Value™ of ₹25.68.
GuruFocus considers Pentokey Organy (India) to be Modestly Overvalued.
Key valuation signals for BOM:524210:
EBIT per Share: ₹0.54
GF Value™: ₹25.68 vs. price of ₹32.83 (27.8% above fair value)
No single metric tells the full story. See the BOM:524210 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pentokey Organy (India) Ltd is engaged in the trading of Pharmaceutical Goods. It manufactures various chemical products such as Acetic acid, Ethyl acetate, and Acetaldehyde and Butyl acetate. These products are used for various purposes including textile processing, pharmaceuticals, pesticides, printing inks, paints, and coatings, perfumes, polyester resins and basic dyes, solvents and many more. The only segment in which the Company engaged in the Trading of Pharmaceutical Products.
48GF Score
Get the complete analysis for BOM:524210
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524210 has been successfully added to your 
